Success in Early Detection

[PressWatch]

From Presswatch

Good News:

Those strange sounding compounds Monoclonal Antibodies are in the news again for all the right reasons.

This time one known as PAM4 has been shown in a small scale trial to have the ability to detect Pancreatic Cancer at an early stage and therefore provide for early intervention. Lets all wish this activity greater success as the earlier the detection the earlier potential favourable outcome.

http://www.ncbi.nlm.nih.gov/pubmed/20810605?dopt=Abstract

Presswatch